United States. CDCs advisory panel could vote on the use of an third shot by Pfizer Inc and partner BioNTech SE’s COVID-19 vaccine on Th, a agency official said while kicking off the two-day panel discussion on Wed.
The Center for Disease Control and Prevention Advisory Committee on immunisation Practices (ACIP) is meeting on September 22-23 to discuss which Americans should get the third vaccine shot, should them be authorized as use by the FDA.
Pfizer has asked the Food and Drug Administration to approve the third shot for all people aged sixteen and over, but an panel by outside advisors to the Food and Drug Administration last Fri said there was alone evidence as an shot being needed along people aged 65 and older. The Food and Drug Administration hasn’t yet said how them plans to proceed.